Notably, HFD-induced glucose homeostasis impairment and systematic insulin resistance were markedly alleviated by the activation of GPER1 with GPER1-specific agonist G1 in female mice (Fig. S8, D–J). Here, GPER1 is linked to Insulin resistance.